Skip to content
Cytognomix Logo
We find and validate mutations that others cannot
  • Home
  • Mission
    • Challenges in genomics: our solutions
  • Products
    • Biodosimetry: Automated Dicentric Chromosome Identifier
      • Testing for Radiation Exposure
    • Mutation Forecaster®
      • Interpretation of mutations in next generation sequencing data: Shannon pipeline
        • Testimonials for the Shannon pipeline
      • Automated Splice Site and Exon Definition Server (ASSEDA)
        • Publications
      • Software for validation of predicted mRNA splicing mutations
        • Testimonials for Veridical
      • Cytognomix User Variation Database (CUVD)
    • Solution capture pools for targeted deep sequencing
    • Targeted array CGH
    • Single copy FISH
      • Customized scFISH probes
      • Standard SC-FISH probes
      • Subtelomeric SC-FISH probes Catalog
    • Product advantages
    • Product Gallery
  • Posts
  • Purchase
    • Pricing
  • Contact Us
  • About us
    • Intellectual Property
    • Applications
  • Resources
  • SiteMap
  • Menu

Nov. 1-3, 2022. Presentation at the International Atomic Energy Agency

Posted on November 7, 2022November 7, 2022 by Peter Rogan

Presentation to Radiation Oncologists and Latin American Radiation Dosimetry Association. Virtual talks on Nov 1. Questions on Nov 3 sponsored by IAEA.

 

 

 

 

 

 

Written by: Peter Rogan on November 7, 2022.
Posted in biodosimetry and tagged biodosimetry, radiation effects, radiation protection, Whole body radiation exposure.

Post navigation

← October 17, 2022. Presentation at…
Nov. 7-10, 2022. Presentation on… →

Recent Posts

  • January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario
  • Oct. 4, 2023. Radiobiology textbook published
  • Sept. 19, 2023. Democratizing ADCI as cloud-based software
  • May 25, 2023. CytoGnomix to present at final RCP meeting of IAEA CRP E35010 (MEDBIODOSE)
A SiteOrigin Theme